scPharmaceuticals Inc. (SCPH): Price and Financial Metrics
SCPH Price/Volume Stats
| Current price | $3.36 | 52-week high | $6.71 |
| Prev. close | $3.52 | 52-week low | $3.08 |
| Day low | $3.27 | Volume | 309,100 |
| Day high | $3.60 | Avg. volume | 272,215 |
| 50-day MA | $4.36 | Dividend yield | N/A |
| 200-day MA | $4.69 | Market Cap | 168.13M |
SCPH Stock Price Chart Interactive Chart >
scPharmaceuticals Inc. (SCPH) Company Bio
scPharmaceuticals Inc. engages in the development and commercialization of transformative pharmaceutical products. The company’s under development products are for heart failure and infectious diseases that include Furoscix that is for treatment of worsening or decompensated heart failure outside of the inpatient setting. scPharmaceuticals Inc. formerly known as scPharmaceuticals LLC. and changed its name to scPharmaceuticals Inc. in March 2014. The company was founded 2013 and is based in Burlington, Massachusetts.
SCPH Price Returns
| 1-mo | -23.81% |
| 3-mo | -37.43% |
| 6-mo | -4.27% |
| 1-year | -38.80% |
| 3-year | -27.90% |
| 5-year | -25.99% |
| YTD | -46.41% |
| 2023 | -12.55% |
| 2022 | 42.83% |
| 2021 | -5.10% |
| 2020 | -6.54% |
| 2019 | 50.53% |
Loading social stream, please wait...